UnicoCell Biomed Co., Ltd. (6794.TW)

TWD 70.8

(0.28%)

Annual Income Statements

(In TWD)
Breakdown 2023 2022 2021 2020 2019
Revenue 24.58 Million 14.39 Million 8.17 Million 3.98 Million 15.73 Million
Cost of Revenue 6.69 Million 6.2 Million 2.34 Million 1.64 Million 3.25 Million
Gross Profit 17.89 Million 8.19 Million 5.83 Million 2.33 Million 12.48 Million
Operating Expenses 17.89 Million 100.3 Million 93.16 Million 113.69 Million 113.52 Million
Selling, General and Administrative Expenses 31.39 Million 25.39 Million 23.3 Million 21.93 Million 20.02 Million
Research and Development Expenses 82.78 Million 74.9 Million 69.86 Million 91.75 Million 93.5 Million
Other Expenses - 1.37 Million 1.54 Million 2.73 Million -
Cost and Expenses 120.86 Million 106.5 Million 95.51 Million 115.33 Million 116.77 Million
Operating Income -96.28 Million -89.89 Million -85.71 Million -108.26 Million -101.04 Million
Interest Expense 1.45 Million 1.25 Million 656 Thousand 944 Thousand 1.22 Million
Income Tax Expense - - - - -
Earnings before Tax -84.1 Million -91.15 Million -86.37 Million -109.2 Million -100.93 Million
Net Income -84.1 Million -91.15 Million -86.37 Million -109.2 Million -100.93 Million
Earnings Per Share Basic -1.56 -2.20 -2.27 -3.05 -3.33
Earnings Per Share Diluted -1.56 -2.20 -2.27 -3.05 -3.33
Weighted Average Shares Outstanding 53.78 Million 41.49 Million 37.97 Million 35.78 Million 30.34 Million
Weighted Average Shares Outstanding (Diluted) 53.78 Million 41.49 Million 37.97 Million 35.78 Million 30.34 Million
Gross Margin 0.73 0.57 0.71 0.59 0.79
EBIT Margin -2.29 -4.56 -7.27 -21.25 -5.82
Profit Margin -3.42 -6.33 -10.56 -27.43 -6.41
EBITDA -56.27 Million -65.62 Million -59.44 Million -84.6 Million -91.6 Million
Earnings Before Tax Margin -3.92 -6.24 -10.48 -27.19 -6.42

Income Statement Charts